OX40L-expressing recombinant modified vaccinia virus Ankara induces potent antitumor immunity via reprogramming TregsNing Yang, Liang Deng, John Choi et al.|The Journal of Experimental Medicine|2023Cited by 24
Intratumoral delivery of engineered recombinant modified vaccinia virus Ankara expressing Flt3L and OX40L generates potent antitumor immunity through activating the cGAS/STING pathway and depleting tumor-infiltrating regulatory T cellsNing Yang, Liang Deng, Yi Wang et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 1
Innate–adaptive IFN cross-talk reprograms myeloid and T cells for antitumor immunity with a second-generation recombinant MVAShuaitong Liu, Liang Deng, Yueqi Wang et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 1
696 Single-cell RNA-seq reveals the critical roles of the STING- and MDA5-mediated cytosolic nucleic acid-sensing pathways as well as IFNAR/STAT2 signaling in recombinant MVA-induced antitumor immunityShuaitong Liu, Liang Deng, Tuo Zhang et al.|Regular and Young Investigator Award Abstracts|2021Cited by 0
Abstract 3280: Type I IFN receptor signaling in myeloid and T cells drives antitumor immunity elicited by intratumoral delivery of immunogenic recombinant modified vaccinia virus AnkaraYueqi Wang, Liang Deng, Shanza Baseer Tariq et al.|Cancer Research|2025Cited by 0